Interaction Guide · Research summary

Can I take Melatonin with Ziprasidone?

Review Melatonin with Ziprasidone: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Review melatonin before adding it to ziprasidone, especially if you already feel sleepy, dizzy or unsteady. The exact combination’s risk has not been quantified.

What this answer covers

Oral melatonin supplement with hydrochloride oral capsules or mesylate intramuscular injection, distinguished by route; botanical preparation and medicine route retained.

Supplement or preparation
Melatonin
Medication ingredient
ziprasidone

Why alertness deserves review

Ziprasidone has cognitive or motor impairment precautions. Melatonin guidance raises alertness concerns, so your symptoms and other medicines matter.

An original schizophrenia study used haloperidol

Melatonin improved sleep without extra morning hangover in a small trial, but all participants were taking haloperidol. That reassuring result does not establish safety with ziprasidone.

Identify the complete product

Bring the amount, preparation and other ingredients to the pharmacist. These sources do not provide a universal safe dose or a protective gap between the supplement and medicine.

Watch for impaired alertness

Ziprasidone can affect alertness and coordination. Avoid driving if affected and contact the prescriber if added sleepiness, confusion or unsteadiness appears after a new product. Severe confusion, fainting or inability to wake needs urgent assessment.

Evidence and practical considerations

Side effects & toxicity

Conditional alertness review based on exact medication effects and supplement precautions; not proven pair-specific CNS depression.

Exact scope
Oral melatonin supplement with hydrochloride oral capsules or mesylate intramuscular injection, distinguished by route; botanical preparation and medicine route retained. with Exact ziprasidone hydrochloride oral capsules or mesylate intramuscular injection, distinguished by route. Exact RxNorm IN115698; hydrochloride oral capsule and mesylate intramuscular formulation distinct. Oral food and antacid findings do not apply to injection absorption.
Medication form and route
oral; intramuscular
Timing or duration
Source-specific single-dose, repeated-dose and observational exposures distinguished.

What remains uncertain

  • No exact-pair co-use trial identified; standalone or other-medicine findings and product differences prevent a uniform risk estimate.

Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed ziprasidone.

Somnolence, QT and electrolyte precautions; low potassium or magnesium requires assessment/correction before proceeding; oral capsules taken with food.

How this applies: Exact RxNorm IN115698; hydrochloride oral capsule and mesylate intramuscular formulation distinct. Oral food and antacid findings do not apply to injection absorption.

No supplement-specific event rate, universal timing rule or untested route/preparation equivalence.

Source 2: official supplement guidance

nccih.nih.gov · Source check Sep 10, 2026

Population: People considering melatonin supplements.

Drowsiness, dizziness and headache can occur; long-term safety information is limited.

How this applies: Preparation-specific evidence; exact ziprasidone co-use is not inferred from another medicine or route.

Not exact antipsychotic co-use or a universal safe dose.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Forty stable schizophrenia outpatients with insomnia.

Sleep quality and duration improved without extra morning hangover.

How this applies: Preparation-specific evidence; exact ziprasidone co-use is not inferred from another medicine or route.

Exact co-medication was haloperidol. No transfer of combination safety to another antipsychotic; small short study.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Research summary published
Article prepared
Current exact available claims adjudicated using original captures and explicit identity and comparator limits.

Article revision: 7049c5bcdabb05a2

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.